- Why Glasgow
- Help & Support
- Media Hub
- Contact Us
The University of Glasgow and NHS Greater Glasgow and Clyde (NHSGGC) today signed a Memorandum of Agreement (MOA) to form the Glasgow Health Sciences Partnership (GHSP).
The aim of the GHSP is to better integrate world-leading research, top quality education and expertise in clinical practice between the University and NHSGGC.
By identifying and moving forward areas of health innovation, such as the implementation of Precision Medicine in Scotland, the GHSP aims to improve health outcomes, deliver better healthcare and generate economic benefits for Glasgow.
The GHSP agreement will also ensure a high level of teaching and learning experiences for a wide range of healthcare staff; and will also aim to rapidly translate research discoveries and innovations into healthcare reality for patients.
The MOA was signed by the University’s Principal and Vice Chancellor, Professor Sir Anton Muscatelli, and John Brown, Chairman of NHSGGC.
Prof Muscatelli said: “On behalf of the University, I am delighted to sign this MOA, which will see this relationship continue to flourish with the creation of the GHSP. The new agreement creates a focus for our continuing efforts to improve health outcomes for the people of our city and beyond, and to bring added benefits to the local and national economy.”
John Brown, Chairman, NHS Greater Glasgow and Clyde, said: “As the largest health authority in the UK, we have a highly talented clinical workforce who contribute significantly to ground-breaking clinical trials and research.
“We have worked closely with the University of Glasgow in the field of medical innovation and research for many years. The strong relationship between the two organisations has been the catalyst for many advances in medical treatment, with improved success rates and better targeted therapies. This continues to benefit patients not only in Greater Glasgow and Clyde but also further afield.”
Professor Dame Anna Dominiczak, Vice Principal and Head of the College of MVLS, said: “Our close partnership with the NHS spans biomedical research, clinical trials and the establishment of the jointly-managed research and teaching infrastructure at the Queen Elizabeth University Hospital, including our Teaching & Learning Centre, the new Clinical Research Facility and the Imaging Centre of Excellence.
“The triple helix approach – collaboration between academia, the NHS and industry – is very important as we strive to further research and investment and continue to lead the way with Precision Medicine, delivering healthcare innovation for Glasgow and beyond.”
Bank of London and The Middle East has bought 1 Atlantic Quay, Glasgow for £55 million from MREFIII, a...Read More
In recent weeks, CoStar have published a number of in-depth articles looking at Glasgow’s commercial property market. Read on...Read More
The University of Glasgow marked the 150th anniversary since work began on the construction of its Gilmorehill campus by...Read More
Sign-up to our email updates for the latest investment opportunities and information in Glasgow. Fill out the form below with your email.